Lotensin Tablet
NDC Package 30698-449-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lotensin (benazepril hydrochloride) tablets is benazepril is used to treat high blood pressure (hypertension). This formulation utilizes a tablet delivery system. Marketed by Validus Pharmaceuticals Llc, this product is identified by NDC 30698-449 and is authorized under FDA application NDA019851.

Identification & Billing

NDC Package Code
30698-449-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
30698-449
11-Digit Billing Format
30698044901
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lotensin
Non-Proprietary Name
Benazepril Hydrochloride
Substance Name
Benazepril Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BENAZEPRIL HYDROCHLORIDE 20 mg/1
Pharmacologic Class
Usage Information
Benazepril is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Benazepril is an ACE inhibitor and works by relaxing blood vessels so that blood can flow more easily.

Regulatory & Marketing

Labeler Name
Validus Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
NDA019851
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-21-1991
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 30698-449-01 identifies a specific commercial package of 100 tablet in 1 bottle of Lotensin, a human prescription drug labeled by Validus Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains benazepril hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Validus Pharmaceuticals Llc on June 21, 1991. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Benazepril is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Benazepril is an ACE inhibitor and works by relaxing blood vessels so that blood can flow more easily.

How is this Validus Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 30698044901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
30698-449-01
11-Digit CMS (5-4-2)
30698-0449-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.